The Non-Executive of Blueberries Medical (Other OTC: BBRRF) is Buying Shares

By Carrie Williams

Today, the Non-Executive of Blueberries Medical (BBRRFResearch Report), Facundo Garreton, bought shares of BBRRF for $8,744.

This recent transaction increases Facundo Garreton’s holding in the company by 10% to a total of $92.58K.

See today’s analyst top recommended stocks >>

Based on Blueberries Medical’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $4,644 and GAAP net loss of -$814,084. In comparison, last year the company earned revenue of $0 and had a GAAP net loss of $1.65 million. Currently, Blueberries Medical has an average volume of 413.75K.

The insider sentiment on Blueberries Medical has been neutral according to 15 insider trades in the past three months. This sentiment is slightly lower than the average sentiment of company insiders in this sector.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Blueberries is a Latin American licensed producer of naturally grown premium quality cannabis with its primary operations ideally located in the Bogota Savannah of central Colombia and operations currently being established in Argentina. The Company is led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries is fully licensed for the cultivation, production, domestic distribution, and international export of CBD and THC-based medical cannabis in Colombia. Blueberries’ combination of leading scientific expertise, agricultural advantages and distribution arrangements has positioned the Company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.